Most academic medical centers (AMCs) have developed financial conflict of interest (COI) policies to govern relationships between their faculty and the drug and medical device industries. The purpose of these policies is to prevent the prospect of personal financial gain by physicians and staff from adversely affecting the core AMC missions of patient care, medical education, and research. Such policies typically regulate a wide range of activities, such as promotional speakers bureaus, industry-funded continuing medical education (CME) programs, access of sales representatives to trainees and staff, and the composition of purchasing and formulary committees.